Clinical Trials Directory

Trials / Completed

CompletedNCT02429856

Posterior Cruciate Retaining (PCR) Versus Posterior Cruciate Substituting (PCS) Total Knee Arthroplasty (TKA)

SCORPIO™ Posterior Stabilized Versus Posterior Retained Total Knee Arthroplasties: Long-term Functional and Radiographic Outcome

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
University of Alberta · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This randomized clinical trial (RCT) examined 10 year outcomes comparing SCORPIO™ Posterior Cruciate Substituting (PCS) versus Posterior Cruciate Retaining (PCR) Total Knee Arthroplasty (TKA) as the primary outcome.

Detailed description

RCT of 100 subjects undergoing primary TKA who were randomized to received either a SCORPIO™ PCS or PCR TKA. Subjects were evaluated pre-operatively and at 2 and 10 years post-operatively using the Western Ontario (WOMAC) Osteoarthritis Index, the RAND-36 and knee range of motion (2 years only). Complication and revision rates were also evaluated.

Conditions

Interventions

TypeNameDescription
DEVICESCORPIO™subjects randomized at surgery to receive 1 of the 2 specified implants

Timeline

Start date
1999-02-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2015-04-29
Last updated
2021-07-27
Results posted
2019-05-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02429856. Inclusion in this directory is not an endorsement.

Posterior Cruciate Retaining (PCR) Versus Posterior Cruciate Substituting (PCS) Total Knee Arthroplasty (TKA) (NCT02429856) · Clinical Trials Directory